AZMN Launches Capital Campaign to Support New Virtual Cancer Caregivers Education Program

The  Virtual Cancer Caregivers Education Programs, VCCEP® address the challenges faced by cancer caregivers.  Delivered online, the VCCEP includes a ‘learning center’ that integrates 15 years of successful cancer caregiver workshops and training, including knowledge and perspectives from cancer patients, cancer caregivers and cancer care professionals.Continue reading

Vidium Animal HealthⓇ and Torigen Pharmaceuticals Partner to Increase Accessibility of Advanced Cancer Care for Canine Patients

 

PHOENIX—October 11, 2022Vidium Animal Health announced today that it has partnered with Torigen Pharmaceuticals, an animal health biologics company, to offer genomic testing and precision medicine to more veterinarians. By opening up the use of personalized, precision medicine to the veterinary marketplace, Vidium and Torigen are providing specialists and general practicing veterinarians with more options to advance the care of dogs with cancer.Continue reading

BIO Announces Appointment of Interim CEO

The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO. King’s appointment follows Dr. Michelle McMurry-Heath stepping down as President and CEO to serve as an Advisor to the Executive Committee of the BIO Board of Directors. The organization is searching for a full-time successor.Continue reading

ASU professor to study new genome editing tools with NIH Innovator Award

There are many human genetic diseases — for example, sickle-cell disease, cystic fibrosis and Hutchinson-Gilford progeria syndrome — that currently have no cure and are caused by point mutations, for which there is a pressing need to develop precision genome editing tools able to correct these mutations with high efficiency and accuracy.

Assistant Professor Audrey Lapinaite from Arizona State University’s School of Molecular Sciences and the Biodesign Institute’s ASU-Banner Neurodegenerative Disease Research Center is working on this problem and has just been awarded a prestigious National Institutes of Health (NIH) Director’s New Innovator Award.Continue reading